Cargando…

Investigating Toxin Diversity and Abundance in Snake Venom Proteomes

Understanding snake venom proteomes is becoming increasingly important to understand snake venom biology, evolution and especially clinical effects of venoms and approaches to antivenom development. To explore the current state of snake venom proteomics and transcriptomics we investigated venom prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasoulis, Theo, Pukala, Tara L., Isbister, Geoffrey K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795951/
https://www.ncbi.nlm.nih.gov/pubmed/35095489
http://dx.doi.org/10.3389/fphar.2021.768015
_version_ 1784641192444559360
author Tasoulis, Theo
Pukala, Tara L.
Isbister, Geoffrey K.
author_facet Tasoulis, Theo
Pukala, Tara L.
Isbister, Geoffrey K.
author_sort Tasoulis, Theo
collection PubMed
description Understanding snake venom proteomes is becoming increasingly important to understand snake venom biology, evolution and especially clinical effects of venoms and approaches to antivenom development. To explore the current state of snake venom proteomics and transcriptomics we investigated venom proteomic methods, associations between methodological and biological variability and the diversity and abundance of protein families. We reviewed available studies on snake venom proteomes from September 2017 to April 2021. This included 81 studies characterising venom proteomes of 79 snake species, providing data on relative toxin abundance for 70 species and toxin diversity (number of different toxins) for 37 species. Methodologies utilised in these studies were summarised and compared. Several comparative studies showed that preliminary decomplexation of crude venom by chromatography leads to increased protein identification, as does the use of transcriptomics. Combining different methodological strategies in venomic approaches appears to maximize proteome coverage. 48% of studies used the RP-HPLC →1D SDS-PAGE →in-gel trypsin digestion → ESI -LC-MS/MS pathway. Protein quantification by MS1-based spectral intensity was used twice as commonly as MS2-based spectral counting (33–15 studies). Total toxin diversity was 25–225 toxins/species, with a median of 48. The relative mean abundance of the four dominant protein families was for elapids; 3FTx–52%, PLA(2)–27%, SVMP–2.8%, and SVSP–0.1%, and for vipers: 3FTx–0.5%, PLA(2)–24%, SVMP–27%, and SVSP–12%. Viper venoms were compositionally more complex than elapid venoms in terms of number of protein families making up most of the venom, in contrast, elapid venoms were made up of fewer, but more toxin diverse, protein families. No relationship was observed between relative toxin diversity and abundance. For equivalent comparisons to be made between studies, there is a need to clarify the differences between methodological approaches and for acceptance of a standardised protein classification, nomenclature and reporting procedure. Correctly measuring and comparing toxin diversity and abundance is essential for understanding biological, clinical and evolutionary implications of snake venom composition.
format Online
Article
Text
id pubmed-8795951
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87959512022-01-29 Investigating Toxin Diversity and Abundance in Snake Venom Proteomes Tasoulis, Theo Pukala, Tara L. Isbister, Geoffrey K. Front Pharmacol Pharmacology Understanding snake venom proteomes is becoming increasingly important to understand snake venom biology, evolution and especially clinical effects of venoms and approaches to antivenom development. To explore the current state of snake venom proteomics and transcriptomics we investigated venom proteomic methods, associations between methodological and biological variability and the diversity and abundance of protein families. We reviewed available studies on snake venom proteomes from September 2017 to April 2021. This included 81 studies characterising venom proteomes of 79 snake species, providing data on relative toxin abundance for 70 species and toxin diversity (number of different toxins) for 37 species. Methodologies utilised in these studies were summarised and compared. Several comparative studies showed that preliminary decomplexation of crude venom by chromatography leads to increased protein identification, as does the use of transcriptomics. Combining different methodological strategies in venomic approaches appears to maximize proteome coverage. 48% of studies used the RP-HPLC →1D SDS-PAGE →in-gel trypsin digestion → ESI -LC-MS/MS pathway. Protein quantification by MS1-based spectral intensity was used twice as commonly as MS2-based spectral counting (33–15 studies). Total toxin diversity was 25–225 toxins/species, with a median of 48. The relative mean abundance of the four dominant protein families was for elapids; 3FTx–52%, PLA(2)–27%, SVMP–2.8%, and SVSP–0.1%, and for vipers: 3FTx–0.5%, PLA(2)–24%, SVMP–27%, and SVSP–12%. Viper venoms were compositionally more complex than elapid venoms in terms of number of protein families making up most of the venom, in contrast, elapid venoms were made up of fewer, but more toxin diverse, protein families. No relationship was observed between relative toxin diversity and abundance. For equivalent comparisons to be made between studies, there is a need to clarify the differences between methodological approaches and for acceptance of a standardised protein classification, nomenclature and reporting procedure. Correctly measuring and comparing toxin diversity and abundance is essential for understanding biological, clinical and evolutionary implications of snake venom composition. Frontiers Media S.A. 2022-01-14 /pmc/articles/PMC8795951/ /pubmed/35095489 http://dx.doi.org/10.3389/fphar.2021.768015 Text en Copyright © 2022 Tasoulis, Pukala and Isbister. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Tasoulis, Theo
Pukala, Tara L.
Isbister, Geoffrey K.
Investigating Toxin Diversity and Abundance in Snake Venom Proteomes
title Investigating Toxin Diversity and Abundance in Snake Venom Proteomes
title_full Investigating Toxin Diversity and Abundance in Snake Venom Proteomes
title_fullStr Investigating Toxin Diversity and Abundance in Snake Venom Proteomes
title_full_unstemmed Investigating Toxin Diversity and Abundance in Snake Venom Proteomes
title_short Investigating Toxin Diversity and Abundance in Snake Venom Proteomes
title_sort investigating toxin diversity and abundance in snake venom proteomes
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795951/
https://www.ncbi.nlm.nih.gov/pubmed/35095489
http://dx.doi.org/10.3389/fphar.2021.768015
work_keys_str_mv AT tasoulistheo investigatingtoxindiversityandabundanceinsnakevenomproteomes
AT pukalataral investigatingtoxindiversityandabundanceinsnakevenomproteomes
AT isbistergeoffreyk investigatingtoxindiversityandabundanceinsnakevenomproteomes